FDA Inspection 1129378 — Jeremy Abramson MD
The FDA completed an inspection of Jeremy Abramson MD on September 4, 2020 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 4, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Boston, MA (United States)